226 related articles for article (PubMed ID: 32057464)
21. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care.
Senter L; O'Malley DM; Backes FJ; Copeland LJ; Fowler JM; Salani R; Cohn DE
Gynecol Oncol; 2017 Oct; 147(1):110-114. PubMed ID: 28800943
[TBL] [Abstract][Full Text] [Related]
22. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
23. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Konstantinopoulos PA; Norquist B; Lacchetti C; Armstrong D; Grisham RN; Goodfellow PJ; Kohn EC; Levine DA; Liu JF; Lu KH; Sparacio D; Annunziata CM
J Clin Oncol; 2020 Apr; 38(11):1222-1245. PubMed ID: 31986064
[TBL] [Abstract][Full Text] [Related]
24. Psychological distress related to BRCA testing in ovarian cancer patients.
Bjørnslett M; Dahl AA; Sørebø Ø; Dørum A
Fam Cancer; 2015 Dec; 14(4):495-504. PubMed ID: 25980896
[TBL] [Abstract][Full Text] [Related]
25. Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.
Bellcross CA; Peipins LA; McCarty FA; Rodriguez JL; Hawkins NA; Hensley Alford S; Leadbetter S
Genet Med; 2015 Jan; 17(1):43-50. PubMed ID: 24946155
[TBL] [Abstract][Full Text] [Related]
26. Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.
Novetsky AP; Smith K; Babb SA; Jeffe DB; Hagemann AR; Thaker PH; Powell MA; Mutch DG; Massad LS; Zighelboim I
Int J Gynecol Cancer; 2013 Jul; 23(6):1016-21. PubMed ID: 23748176
[TBL] [Abstract][Full Text] [Related]
27. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Colombo N; Huang G; Scambia G; Chalas E; Pignata S; Fiorica J; Van Le L; Ghamande S; González-Santiago S; Bover I; Graña Suárez B; Green A; Huot-Marchand P; Bourhis Y; Karve S; Blakeley C
J Clin Oncol; 2018 May; 36(13):1300-1307. PubMed ID: 29558274
[TBL] [Abstract][Full Text] [Related]
29. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
[TBL] [Abstract][Full Text] [Related]
30. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.
Clevenger L; Schrepf A; Degeest K; Bender D; Goodheart M; Ahmed A; Dahmoush L; Penedo F; Lucci J; Thaker PH; Mendez L; Sood AK; Slavich GM; Lutgendorf SK
Cancer; 2013 Sep; 119(17):3234-41. PubMed ID: 23797955
[TBL] [Abstract][Full Text] [Related]
31. BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
Høberg-Vetti H; Bjorvatn C; Fiane BE; Aas T; Woie K; Espelid H; Rusken T; Eikesdal HP; Listøl W; Haavind MT; Knappskog PM; Haukanes BI; Steen VM; Hoogerbrugge N
Eur J Hum Genet; 2016 Jun; 24(6):881-8. PubMed ID: 26350514
[TBL] [Abstract][Full Text] [Related]
32. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Schrader KA; Hurlburt J; Kalloger SE; Hansford S; Young S; Huntsman DG; Gilks CB; McAlpine JN
Obstet Gynecol; 2012 Aug; 120(2 Pt 1):235-40. PubMed ID: 22776961
[TBL] [Abstract][Full Text] [Related]
33. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
Maheu C; Bouhnik AD; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Julian-Reynier C
Psychooncology; 2014 Apr; 23(4):420-7. PubMed ID: 24127257
[TBL] [Abstract][Full Text] [Related]
34. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
Lin J; Sharaf RN; Saganty R; Ahsan D; Feit J; Khoury A; Bergeron H; Chapman-Davis E; Cantillo E; Holcomb K; Blank SV; Liu Y; Thomas C; Christos PJ; Wright DN; Lipkin S; Offit K; Frey MK
Gynecol Oncol; 2021 Aug; 162(2):506-516. PubMed ID: 34023131
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
[TBL] [Abstract][Full Text] [Related]
36. Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
Frey MK; Kahn RM; Chapman-Davis E; Tubito F; Pires M; Christos P; Anderson S; Mukherjee S; Jordan B; Blank SV; Caputo TA; Sharaf RN; Offit K; Holcomb K; Lipkin S
J Clin Oncol; 2020 May; 38(13):1389-1397. PubMed ID: 31922918
[TBL] [Abstract][Full Text] [Related]
37. Impact of BRCA1 testing on women with cancer: a pilot study.
Wood ME; Mullineaux L; Rahm AK; Fairclough D; Wenzel L
Genet Test; 2000; 4(3):265-72. PubMed ID: 11142757
[TBL] [Abstract][Full Text] [Related]
38. Referral patterns for genetic counselling of women diagnosed with tubo-ovarian or peritoneal high-grade serous carcinoma (HGSC) within the Auckland Gynaecological Oncology Centre.
Burling MJ; Gamet K; Eva L; Tan AL
Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):444-449. PubMed ID: 30883681
[TBL] [Abstract][Full Text] [Related]
39. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
40. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
